Spiranza (nusinersen) is the only treatment currently available for spinal muscular atrophy (SMA) and is delivered intrathecally. In children and adults with long disease duration is usual the presence of spinal deformities and previous spinal surgery that precludes the use of standard techniques of lumbar puncture. In clinical practice, it is becoming even more frequent the need of new ways of accessing the intrathecal space, especially when a repetitive administration route is needed. To present the complications and benefits of lumbar catheter placement for Spiranza administration in a patient with previous spinal surgery.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...